We asked our readers to give us feedback into how much they knew about GLP-1 Analogs and a broad cross-section replied. Take a look at 5 of the questions and how your colleagues answered....
Advertisement
It appears that most of you knew that a large amount of GLP-1 production is lost by the time diabetes develops and that this contributes heavily to difficulties controlling glucose.
The use of GLP-1 agonists are not currently indicated with insulin and it was interesting to see that over 50% of all nurses, nurse practitioners, and pharmacists as well as 45% of dietitians thought it was indicated with insulin. Only physicians were well versed in the indications.
Even though many more prescriptions were written for DPP-4 inhibitors than GLP-1 agonists in 2009 most of you knew that there is more A1c lowering power in GLP-1 agonists.
The use of a DPP-4 Inhibitor rather than a GLP-1 agonist is even more puzzling when you consider that most everyone knew that there cardiovascular benefits associated with GLP-1 agonists as well.
I was surprised to see that some professionals felt that GLP-1 Agonists are available orally and can only assume that some feel that DPP-4 inhibitors and GLP-1 Agonists are the same.
Click below to access other articles in this series:
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2012 Diabetes In Control, Inc.. All rights reserved.
Entries (RSS News)
